Amgen, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0311621009
USD
349.77
1.97 (0.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Halozyme Therapeutics, Inc.
Amgen, Inc.
Illumina, Inc.
Gilead Sciences, Inc.
Moderna, Inc.
Bio-Techne Corp.
BioMarin Pharmaceutical, Inc.
Biogen, Inc.
Elanco Animal Health, Inc.
Vaxcyte, Inc.
Immunovant, Inc.

Why is Amgen, Inc. ?

1
High Management Efficiency with a high ROCE of 22.31%
2
Positive results in Dec 25
  • DIVIDEND PER SHARE(HY) Highest at USD 4.3
  • INTEREST COVERAGE RATIO(Q) Highest at 777.03
  • RAW MATERIAL COST(Y) Fallen by 1.35% (YoY)
3
With ROCE of 18.91%, it has a attractive valuation with a 4.48 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 10.67%, its profits have risen by 62.9% ; the PEG ratio of the company is 0.4
4
High Institutional Holdings at 81.91%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Amgen, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Amgen, Inc. for you?

Low Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Amgen, Inc.
10.67%
0.51
28.97%
S&P 500
16.12%
0.84
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.79%
EBIT Growth (5y)
2.75%
EBIT to Interest (avg)
4.81
Debt to EBITDA (avg)
2.91
Net Debt to Equity (avg)
7.83
Sales to Capital Employed (avg)
0.49
Tax Ratio
10.78%
Dividend Payout Ratio
66.92%
Pledged Shares
0
Institutional Holding
81.91%
ROCE (avg)
22.31%
ROE (avg)
234.10%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
22.80
EV to EBIT
23.68
EV to EBITDA
15.75
EV to Capital Employed
4.48
EV to Sales
6.62
PEG Ratio
0.36
Dividend Yield
1.95%
ROCE (Latest)
18.91%
ROE (Latest)
100.80%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
DIVIDEND PER SHARE(HY)

Highest at USD 4.3

INTEREST COVERAGE RATIO(Q)

Highest at 777.03

RAW MATERIAL COST(Y)

Fallen by 1.35% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 534.83 %

NET SALES(Q)

Highest at USD 9,896 MM

-1What is not working for the Company
CASH AND EQV(HY)

Lowest at USD 18,574 MM

Here's what is working for Amgen, Inc.

Interest Coverage Ratio
Highest at 777.03
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Dividend per share
Highest at USD 4.3 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (USD)

Net Sales
Highest at USD 9,896 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Debt-Equity Ratio
Lowest at 534.83 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by 1.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Amgen, Inc.

Cash and Eqv
Lowest at USD 18,574 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents